Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Meridia (sibutramine hydrochloride monohydrate) Capsule, Abbott NDA 20-632/17 9/25/03 9/30/03 Meridia (sibutramine hydrochloride monohydrate) Capsule, Knoll Pharmaceutical NDA 20-632/S-008/11 2/16/01 2/27/01 2/27/01 Meridia Indications: Management of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a reduced calorie diet. | Meridia (Sibutramine HCL Monohydrate) Capsules, Abbott, Labeling Revision & Package Change | Meridia (sibutramine HCL monohydrate), Abbott Labs, Labeling Revision | Meridia (sibutramine hydrochloride monohydrate) Capsules, Global Pharma, Patient Population Altered | Meridia (Sibutramine Hydrochloride Monohydrate) Capsules, Abbott Labs, Labeling Revision | Meridia Capsule, Abbott, Labeling Revision | Meridia (sibutramine hydrochloride) Capsules, Abbott Laboratories, Labeling Revision | Meridia (sibutramine hydrochloride) Capsules, Abbott Laboratories, Labeling Revision | Meridia (sibutramine hydrochloride) Capsules, Abbott Laboratories, Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com